Introduction
============

With the development of surgical techniques and biomaterials in the field of dentistry, dental implant is a common, reliable option for edentulous patients. In a minor bony defect like bony dehiscence or fenestration, guided bone regeneration (GBR) procedure can cover exposed implant threads after dental implant placement. Research on GBR \[[@b1-mprs-36-116]--[@b3-mprs-36-116]\] demonstrates successful clinical outcomes. Though GBR is safe and conservative in comparison with other aggressive bone graft techniques, potential surgical complications, such as wound dehiscence causing barrier membrane exposure, should be considered, especially for submerged implants \[[@b4-mprs-36-116]\]. Wound dehiscence is partially attributed to the use of a barrier membrane \[[@b5-mprs-36-116]\]. Clinically, wound dehiscence is troublesome, and carries a high risk of complications such as wound infections, graft loss, or implant failure \[[@b6-mprs-36-116]\]. Although generally concern over dental implant surgery complications is focused on clinical outcomes such as implant survival or grafted bone loss, dehiscence of an intraoral wound is undesirable \[[@b7-mprs-36-116],[@b8-mprs-36-116]\]. Patients with wound dehiscence are nervous about food ingestion and anxious about contamination of the surgical wound. Extra care time is required to treat exposed membrane, above regular healing time. For the highly qualified dental service, it is important to be aware of risks influencing of wound dehiscence.

This study evaluated GBR clinical outcomes and estimated risks influencing wound dehiscence after GBR in dental implant surgery.

Material and Methods
====================

The Institutional Review Board at Seoul National University Bundang Hospital (B-0808/060-102) approved this retrospective study. The patients who received dental implant therapy with GBR procedure by an oral surgeon at Seoul National University Bundang Hospital (Seongnam, Korea) from June 2004 to May 2007 were included in this study. Those patients classified as American Society of Anesthesiologist (ASA) class I or II were included. All patients who took antiplatelet agents discontinued medication for five to seven days before implant surgery. Postoperative prescriptions included cephalexin 1.0 g (clindamycin 300 mg in cases of allergy) with talniflumate 370 mg three times per day for five days, and chlorhexine gluconate (Hexmedine; Bukwang Co., Seoul, Korea) mouth-rinse twice per day for 10 days. Sutures were removed 10 days after surgery. Routine post-operative checks were scheduled at two, four, and 12 weeks. Patients with wound dehiscence were checked twice a week, until secondary wound healing was completed, with additional chlorhexine gluconate mouth-rinses. Second-stage surgery was performed after six months of healing time.

Clinical outcomes of GBR cases, including surgical complications and failure, were evaluated in terms of patient-related factors, surgery-related factors and material-related factors. Gender, age, general health state and smoking are patient-related factors. Implant location, the number of implants and immediate implant are surgery-related factors. When simultaneous implant placement was done on the tooth-extracted site, that was designated an immediate implant. Implant system connection type, implant fixture length and diameter, membrane type and main graft in are material-related factors. The implant systems were either external hex or internal hex on the base of the abutment connection. The external hex implant systems used in this study were USII, USIII (Osstem Implant Co., Busan, Korea), and TiUnite (Nobel Biocare AB, Gothenburg, Sweden). The internal hex implant systems were GSII (Osstem Implant Co.), Implantium (Dentium Co., Yongin, Korea). Implant length was sorted as short (≤10.0 mm), standard (\>10.0 mm, \<13.0 mm), or long (≥13.0 mm). Implant diameter was sorted as narrow (≤3.5 mm), standard (\>3.5 mm, \<4.5 mm), or wide (≥4.5 mm). The barrier membranes were either resorbable or non-resorbable membranes. The resorbable membranes used in this study were Biogide (Geistlich Pharma AG, Wolhusen, Switzerland), Biomesh (Samyang Co., Seoul, Korea), and Ossix (Colbar LifeScience Ltd., Herzliya, Israel). The non-resorbable membranes were Frios^®^ BoneShield (Frident, Mannheim, Germany) and Goretex (e-PTFE; W.L. Gore & Associates Inc., Flagstaff, AZ, USA). Main grafts were autogenic, allogenic, and heterogenic according to the graft material occupying the major portion (over 75% of total volume of grafted material). The allogenic graft material used were Dembone (Pacific Tissue Bank, Los Angeles, CA, USA), Orthoblast^®^ II (Integra OrthoBiologics Inc., Irvine, CA, USA), and Regenafil (Exactech Inc., Gainesville, FL, USA); and the heterogenic graft materials were BBP (OCT Inc., Cheonan, Korea), Biocera (OCT Inc.), and BioOss (Geistlich Pharma AG).

The relationships between categorical variables were analyzed by chi-square test or Fisher's exact test. To assess factors influencing wound dehiscence, multivariate logistic regression was applied with the variables that passed cut-off significance (*P* \<0.25) in the preliminary univariate analysis. Statistical analyses used PASW Statistics ver. 18.0 for Windows (IBM Co., Armonk, NY, USA). Null hypotheses of no difference were rejected if *P*-values were less than 0.05, or equivalently, if the 95% confidence intervals of risk point estimates excluded 1.

Results
=======

1.. Clinical outcome
--------------------

One hundred and fifteen cases (male: 61 cases, female: 54 cases) from 99 patients (male: 52 patients, female: 47 patients) were included in this study. Two hundred and two implants (male: 113, female: 89) were placed in this study. The age range was between 25 and 77 years and the average was 52.62 (standard deviation=11.01) years. The types of surgical complications and occurrence are in [Table 1](#t1-mprs-36-116){ref-type="table"}. The commonest complication was wound dehiscence, detected in 22 cases (19.1%). Eight implants were removed due to osseointegration failure. Two years after final prostheses, the success rate was 96.0%.

2.. Factors influencing ([Table 2](#t2-mprs-36-116){ref-type="table"})
----------------------------------------------------------------------

### 1). Patient-related factors

Seventeen of 61 cases among the males and five of 54 cases among the females developed wound dehiscence. Male patients had a significantly higher risk of wound dehiscence compared to female patients (*P* =0.011).

There were 50 cases (88 implants) with general disease (ASA class II). Twelve cases with general disease had wound dehiscence. Ten of 65 healthy (ASA class I) cases also developed membrane exposure. There was no significant difference between groups (*P* =0.244).

There were five smokers in this study, whose numbers were too few for analysis.

### 2). Surgery-related factors

The flap location could be anterior maxilla, posterior maxilla, anterior mandible, or posterior mandible. A higher risk of membrane exposure was noted with anterior maxillary flaps (28.6%) and anterior mandibular group (28.6%). There was no significant complication risk from flap location (*P* =0.630).

The number of placed implants was closely related to the size of the flap. There were 22 cases in which more than three implants were placed, and wound dehiscence was reported in six such cases (27.3%). There was no significant complication risk from implant number (*P* =0.752).

The immediate group included cases of simultaneous implant placement at the time of tooth extraction. The immediate and delayed groups were considered different groups because additional flap tension would be expected for the primary wound closure. In this study, 17 of 89 cases in the delayed group and five of 26 cases in immediate group developed wound dehiscence. There was no significant complication risk from implant timing (*P* =0.988).

### 3). Material-related factors

From the 47 cases of external hex connection type implants, 13 cases developed wound dehiscence. Nine cases from 68 cases of internal hex connection type had membrane exposure. The risk of wound dehiscence was higher with external hex connection type (*P* =0.058).

The highest risk of wound dehiscence (28.6%) was observed with long implants (10 of 35 cases), no significant difference (*P* =0.089). There was no significant complication risk from implant diameter (*P* =0.555).

Nineteen of 97 cases (19.6%) of resorbable and three of 18 cases (16.7%) of non-resorbable membrane developed wound dehiscence, no difference (*P* =0.772).

Six of 19 cases of autogenic group and 13 of 47 cases of heterogenic group developed wound dehiscence. Three of 49 cases of allogenic group showed membrane exposure. A significant complication risk was detected among groups (*P* =0.012).

All of the graft materials in autogenic group and heterogenic group were particle type. One graft material (10 cases) in allogenic group was particle type and two graft materials (39 cases) in allogenic group were gel type. Twenty of 76 cases with particle type graft material and two of 39 cases with gel type graft material had wound dehiscence, a significant risk (*P* =0.020).

Variables influencing wound dehiscence were evaluated by univariate logistic regression analysis ([Table 3](#t3-mprs-36-116){ref-type="table"}). The cut off *P*-value was 0.25. Gender, general health state, smoking, connection type, implant length and main graft were included in the univariate logistic regression analysis.

The variables included in multiple logistic regression models were gender, main graft, and connection type ([Table 4](#t4-mprs-36-116){ref-type="table"}). A higher risk of wound dehiscence was observed in males (odds ratio=4.279, *P* =0.014). Allogenic grafts had the lowest risk of wound dehiscence (odds ratio=0.106, *P* =0.006).

Discussion
==========

GBR was developed in the late 1980s and early 1990s \[[@b9-mprs-36-116],[@b10-mprs-36-116]\]. This predictable procedure is now widely used in implant surgery for minor intraoral bony defects. One of the most frequent surgical complications of GBR procedure is wound dehiscence. To avoid wound dehiscence, a tension-free flap approximation is important \[[@b11-mprs-36-116]\]. Irritation from dentures and remaining teeth can cause wound dehiscence \[[@b12-mprs-36-116]\]. There are many reports of wound dehiscence as complication of implant surgery \[[@b13-mprs-36-116],[@b14-mprs-36-116]\]. With GBR, wound dehiscence results in barrier membrane exposure. An increased rate of wound dehiscence (30%) was noted with barrier membrane use \[[@b15-mprs-36-116]\]. Re-suture is possible to manage small wound dehiscence occurring within 48 hours. However, in cases of large (more than 2.0 cm) wound dehiscence occurring after more than two days, the margins of the wound should be excised before re-suture. This is problematic and frequently does not work well \[[@b4-mprs-36-116]\]. Usually, wound dehiscence with traumatized wound margins was treated by secondary intention. Granulation tissue initially covers the dehisced wound and epithelialization follows \[[@b16-mprs-36-116]\]. In this study, all cases of wound dehiscence were treated as secondary wound healing. Chlorhexine gluconate mouth-rinse was used to prevent infection. There were no intentional removals of membrane or graft material by subsequent infection.

There are several points that clinicians should consider. If membrane exposure is found, the average time for initial wound healing (one to two weeks) will be extended to six to eight weeks. More frequent exams (more than 10 dental appointments) are needed for wound checking and dressing, above the usual three to five dental appointments. An additional cost is incurred for dental treatment fee and chlorhexine gluconate mouth-rinse. To most patients, money and time for treatment poses a challenge. Furthermore, implant surgery is the first step of implant treatment. Sometimes, the occurrence of surgical complication affects the relationship between surgeon and the patient for the entire duration of treatment. Overall satisfaction with implant treatment is lowered, indirectly influencing clinical outcome.

Premature exposure of non-resorbable and resorbable membranes leads to extensive resorption of the bone graft and lack of continuity between the graft and the recipient bed \[[@b17-mprs-36-116],[@b18-mprs-36-116]\]. Implants placed simultaneously with prematurely exposed barrier membranes show significantly higher crestal bone loss up to 24 months after placement compared with non-exposed membranes \[[@b19-mprs-36-116]\].

Interestingly, male patients had a significantly higher risk of wound dehiscence compared to female patients. A possible partial explanation includes the carelessness of male patients and higher prevalence of general disease and smoking. Though it was excluded in the final model, higher bleeding tendency contributed to additional pressure on the flap.

To protect the flap, supplementary procedures such as surgical pack and surgical splint application are recommended, especially for male patients. Postoperative instruction including warning on the wound maintenance would be helpful. Interestingly, the patients who had controlled general disease (ASA II group) had a higher risk of complications than healthy patients, although they were confirmed to have no bleeding tendency or healing problem (data not shown).

Although it is difficult to separate out smoking as a single risk for implant failure, delayed wound healing and peri-implant infection are thought to be significant in the high short term failure rate in smokers \[[@b20-mprs-36-116],[@b21-mprs-36-116]\]. However, smokers in this study did not have a significantly higher risk of wound dehiscence. Two of five cases (40%) developed wound dehiscence. The number of smokers was too small to evaluate influence of smoking on wound dehiscence in this study.

There was no difference of risk of wound dehiscence by flap location. It was difficult to find simple GBR cases from the maxillary and anterior mandibular areas in this study. A combination procedure with veneer bone graft or ridge splitting was more frequent than simple GBR in the anterior maxillary and anterior mandibular areas. Also, the sinus lift procedure was combined in the posterior maxillary area.

There was no evidence of direct connection between flap size and wound dehiscence. However, if the incision is too small and the flap size is insufficient, there would be excessive pressure on the flap increasing the risk of tearing the mucosal flap. Impinged mucosal flaps would likely undergo necrosis, delay healing, and possibly contribute to implant failure \[[@b22-mprs-36-116]\]. It is recommended that the flap size be sufficient to expose operating field because more wound dehiscence is expected with smaller flaps. It was interesting that the patient with one or two implant placements had a higher risk of wound dehiscence than those who received three or four implant placements in this study.

Chen *et al.* \[[@b23-mprs-36-116]\] reported that more wound dehiscence would be expected with delayed implant placement because of lack of tensile strength of the soft tissue flap \[[@b24-mprs-36-116]\]. It was also reported that immediate implant placement may be adversely affected by the presence of infection and lack of soft tissue closure and flap dehiscence over the extraction site \[[@b25-mprs-36-116],[@b26-mprs-36-116]\]. Implant placement delayed for several weeks after tooth extraction allows time for bone regeneration at the base and periphery of the socket, thereby reducing the dimensions of the socket and avoiding the need for augmentation procedures \[[@b27-mprs-36-116]\]. However, the concomitant resorption of buccal bone may increase the need for augmentation bucco-lingually. An interesting observation was a lower risk of wound dehiscence and membrane exposure with delayed implant placement, regardless of the type of membrane used \[[@b28-mprs-36-116],[@b29-mprs-36-116]\]. Immediate implant placement after extraction did not change clinical outcome in this study.

Tal \[[@b14-mprs-36-116]\] reported that the risk of wound dehiscence was higher in external hex implants. Schwarts-Arad *et al.* \[[@b30-mprs-36-116]\] reported the risk of wound complication in implants with a flat cover screw lower than with a high cover screw. Adell *et al.* \[[@b31-mprs-36-116]\] inserted the implants subcrestally aimed at the level of the external hex of the implant with the bony crest. If the implant's shoulders were inserted below the crestal bone, cortical bone support was reduced at the implant's neck. Conversely, if the level of external hex was located supracrestally, the cover screw would be located more superiorly than internal connection. It was thought that the cover screw loosening was more problematic in external hex types.

Implants longer than 13.0 mm led to a higher risk of wound dehiscence in this study. Usually, long implants were used for more bony deficiency cases, with intentional supraplantation to use the implant as a tenting pole.

Membrane micromotion was hypothesized to decrease the regenerative response by forming a layer of soft tissue under the membrane \[[@b6-mprs-36-116]\]. In the ill-fixed cases, more irritation on surrounding tissue would be expected. While not settled, a lower risk of premature membrane exposure has been reported in studies using collagen membranes \[[@b29-mprs-36-116],[@b32-mprs-36-116]\]. A more advanced type of collagen membrane is available that is resistant to animal and bacterial collagenase when prematurely exposed. Although collagen barriers offer improved soft tissue response, they lacked the ability to maintain adequate defect space \[[@b33-mprs-36-116],[@b34-mprs-36-116]\]. There are extensive studies on non-resorbable membrane in animals and humans \[[@b35-mprs-36-116],[@b36-mprs-36-116]\]. The use of titanium mesh as a barrier maximizes graft containment and eliminates the space maintenance collapse problems associated with conventional membranes \[[@b37-mprs-36-116]\]. In this study, there was no difference between non-resorbable membrane and resorbable membrane for the risk of wound dehiscence.

To the best of our knowledge, there is no report that the type of graft material affects wound dehiscence. In this study, allogenous graft material was superior to heterogenic graft material as the main graft. Possibly the physical properties of graft material such as malleability, plasticity, deformability are related to lower risk. Most of the allogenous material in this study contained base or carrier. Compared to heterogenous and autogenous materials, allogenous materials are better to adapt the flap against pressure. The cases using Orthoblast^®^ II (containing reverse thermal poloxamer as carrier) and Regenafil as a main graft had a lower risk of wound dehiscence in this study \[[@b38-mprs-36-116],[@b39-mprs-36-116]\]. Gel type material was easier to manipulate and to apply than granule or particle type, and collapsible and malleable, so it might be more easily adapted against pressure induced from the surrounding tissue. It did not mean that allogenous graft material was better. The physical properties of base or carrier materials should be considered.

Conclusion
==========

From the results, gender and main graft are the factors influencing wound dehiscence. To reduce wound dehiscence after GBR, instruction on postoperative care with supplementary procedure for the protection of the wound dehiscence is recommended for the patients, especially male patients. A main graft with a gel base helps prevent wound dehiscence.

###### 

Summary of complications

  Types of complication          Case (n=115)   Implant (n=202)
  ------------------------------ -------------- -----------------
  Wound dehiscence               22 (19.1)      42 (20.8)
  Infection                      1 (0.9)        3 (1.5)
  Numbness                       2 (1.7)        6 (3.0)
  Failure of osseo-integration   7 (6.1)        8 (4.0)

Values are presented as number (%).

###### 

Risk factors for wound dehiscence

  Variable                                GBR case (implants)   WD case (implants)   χ^2^    *P*-value
  --------------------------------------- --------------------- -------------------- ------- -----------
  Age (yr)                                                                           0.052   0.820
    25∼52                                 55 (100)              11 (21)                      
    53∼78                                 60 (102)              11 (21)                      
  Gender                                                                             6.412   0.011
    Male                                  61 (113)              17 (33)                      
    Female                                54 (89)               5 (9)                        
  General health state                                                               1.356   0.244
    ASA II                                50 (88)               12 (21)                      
    ASA I                                 65 (114)              10 (21)                      
  Smoking                                                                            1.472   0.225
    Smoker                                5 (10)                2 (3)                        
    Non-smoker                            110 (192)             20 (39)                      
  Location                                                                           1.730   0.630
    Anterior maxilla                      14 (27)               4 (8)                        
    Posterior maxilla                     19 (34)               4 (7)                        
    Anterior mandible                     7 (10)                2 (4)                        
    Posterior mandible                    75 (131)              12 (23)                      
  Number of placed implants (flap size)                                              1.206   0.752
    1                                     54 (54)               9 (9)                        
    2                                     39 (78)               7 (14)                       
    3                                     18 (54)               5 (15)                       
    4                                     4 (16)                1 (4)                        
  Immediate implant                                                                  0.000   0.988
    Delayed                               89 (165)              17 (34)                      
    Immediate                             26 (37)               5 (8)                        
  Connection type                                                                    3.738   0.053
    External hex                          47 (94)               13 (29)                      
    Internal hex                          68 (108)              9 (13)                       
  Implant length                                                                     4.830   0.089
    Short                                 29 (64)               2 (7)                        
    Standard                              51 (78)               10 (17)                      
    Long                                  35 (60)               10 (18)                      
  Implant diameter                                                                   1.179   0.555
    Narrow                                12 (20)               3 (4)                        
    Standard                              72 (125)              15 (29)                      
    Wide                                  31 (57)               4 (9)                        
  Membrane types                                                                     0.084   0.772
    Resorbable                            97 (170)              19 (37)                      
    Non-resorbable                        18 (32)               3 (5)                        
  Main graft                                                                         8.792   0.012
    Autogenic                             19 (34)               6 (9)                        
    Allogenic                             49 (81)               3 (9)                        
    Heterogenic                           47 (87)               13 (24)                      

Values are presented as number (%).

GBR, guided bone regeneration; WD, wound dehiscence; ASA, American Society of Anesthesiologist.

###### 

Univariate analysis of risk factors for wound dehiscence

  Variable included in logistic regression   Odds ratio   95% confidence interval   *P*-value
  ------------------------------------------ ------------ ------------------------- -----------
  Gender                                                                            
    Male                                     3.786        1.290∼11.116              0.015
    Female                                   1.000                                  
  General health state                                                              
    ASA II                                   1.737        0.682∼4.426               0.247
    ASA I                                    1.000                                  
  Smoking                                                                           
    Smoker                                   3.000        0.470∼19.149              0.245
    Non-smoker                               1.000                                  
  Connection type                                                                   
    External hex                             2.507        0.970∼6.474               0.058
    Internal hex                             1.000                                  
  Graft                                                                             0.020
    Autogenic                                1.000                                  
    Allogenic                                0.141        0.031∼0.644               0.011
    Heterogenic                              0.828        0.260∼2.641               0.750
  Implant length                                                                    0.117
    Short                                    0.440        0.037∼0.929               0.185
    Standard                                 0.336        0.223∼1.670               0.610
    Long                                     1.000                                  

ASA, American Society of Anesthesiologist.

###### 

Multivariate analysis by logistic regression of risk factors for wound dehiscence

  Variable        Odds ratio   95% confidence interval   *P*-value
  --------------- ------------ ------------------------- -----------
  Gender                                                 
    Male          4.279        1.345∼13.611              0.014
    Female        1.000                                  
  Main graft                                             0.014
    Autogenic     1.000                                  
    Allogenic     0.106        0.021∼0.532               0.006
    Heterogenic   0.635        0.178∼2.264               0.484
